Literature DB >> 21057162

Liver diseases in Mexico and their associated mortality trends from 2000 to 2007: A retrospective study of the nation and the federal states.

Nahum Méndez-Sánchez1, Elsy García-Villegas, Beatriz Merino-Zeferino, Soledad Ochoa-Cruz, Antonio R Villa, Herlinda Madrigal, Ramón A Kobashi-Margáin, Ylse Gutiérrez-Grobe, Norberto Chávez-Tapia, Guadalupe Ponciano-Rodríguez, Misael Uribe.   

Abstract

INTRODUCTION: Liver disease is a major health issue in Mexico. Although several studies have been performed to analyze the impact of liver diseases on the Mexican population, none has compared the prevalence and impact of liver disease between states within Mexico. AIM: To analyze trends in mortality associated with liver diseases from 2000 to 2007 at the national and state levels.
METHODS: Data was obtained from the Ministry of Health (number of deaths) and the National Population Council (CONAPO) (population at risk) and mortality rates were analyzed using statistical software.
RESULTS: Mortality due to viral hepatitis, liver tumors, and cirrhosis increased over the study period. Alcohol-related mortality decreased but was still the main cause of liver-related deaths. Viral hepatitis infection occurred predominantly in the northern states and liver tumors occurred predominantly in the central region. Alcohol-related deaths were elevated along the Pacific shoreline and deaths associated with cirrhosis occurred mainly in the central and southern states.
CONCLUSION: Incidence of liver-related mortality has increased and will continue to do so in the future.

Entities:  

Mesh:

Year:  2010        PMID: 21057162

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  5 in total

1.  Risk factors for liver disease and associated knowledge and practices among Mexican adults in the US and Mexico.

Authors:  Yvonne N Flores; Cathy M Lang; Jorge Salmerón; Roshan Bastani
Journal:  J Community Health       Date:  2012-04

2.  Nuclear receptors in nonalcoholic Fatty liver disease.

Authors:  Jorge A López-Velázquez; Luis D Carrillo-Córdova; Norberto C Chávez-Tapia; Misael Uribe; Nahum Méndez-Sánchez
Journal:  J Lipids       Date:  2011-12-08

3.  Pentoxifylline Plus Prednisolone versus Pentoxifylline Only for Severe Alcoholic Hepatitis: A Randomized Controlled Clinical Trial.

Authors:  Bk De; Sk Mandal; D Sau; S Mani; S Chatterjee; Ss Mondal; K Bhattacharya; K Sil; R Bhattacharya
Journal:  Ann Med Health Sci Res       Date:  2014-09

4.  Hepatitis C in the three main health institutions in Mexico: a 13-year mortality and hospitalization analysis.

Authors:  Iván de Jesús Ascencio-Montiel
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2020-02-07       Impact factor: 1.846

5.  Mortality From Alcohol-Related Liver Cirrhosis in Mexico (2000-2017).

Authors:  Myrna L Yeverino-Gutiérrez; María Del R González-González; Omar González-Santiago
Journal:  Front Public Health       Date:  2020-10-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.